Cholesteryl esters: fueling the fury of prostate cancer.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 24606894.
- Also identified by DOI 10.1016/j.cmet.2014.02.012.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tumors display distinct metabolic programs, and altered lipid metabolism is emerging as an important process in cancer. In this issue, Yue et al. (2014) report that aberrant cholesteryl ester accumulation is found in advanced prostate cancers with PTEN loss and PI3K/AKT activation. Importantly, inhibition of cholesterol esterification impaired cancer aggressiveness.
Medical subject headings
- Cholesterol Esters
- PTEN Phosphohydrolase
- Phosphatidylinositol 3-Kinase
- Proto-Oncogene Proteins c-akt